研究業績

●英文

2025年

Yoshida N, Maeda S. Development of a visual inspection method for identifying falsified medicines obtained by personal import via the Internet. BPB Reports 8(2):27-37, 2025.

Mizuno S, Gake S, Takabayashi M, Ito Y, Sanada H, Sugimoto N, Maeda A, Tamamura T, Sawamoto K, Hara Y, Ohi Y, Tsuji C, Shiomoto Y, Kato Y, Fujita A, Shimada T, Miyamoto K, Sai Y. Effect of obesity on pharmacokinetics of transdermal fentanyl: Single-center retrospective study and animal study. Drug Metab Pharmacokinet. 60:101035, 2025.

Arihara H, Nagamatsu H, Hayakawa Y, Mase H, Araya T, Kita T. Association of pretreatment albumin-bilirubin grade with hepatotoxicity and efficacy in EGFR-TKIs therapy for NSCLC. Cancer Diagn Progn. 5(1), 2025.

2024年

Mizuno S, Takabayashi M, Makihara H, Ogai K, Tsukui K, Ito Y, Kawakami T, Hara Y, Fujita A, Tokudome Y, Akase T, Kato Y, Shimada T, Sai Y. Effect of changes in skin properties due to diabetes mellitus on the titration period of transdermal fentanyl: single-center retrospective study and diabetic animal model study. J Pharm Health Care Sci. 10:80, 2024.

Wen S, Arakawa H, Yokoyama S, Shirasaka Y, Higashida H, Tamai I. Functional identification of soluble uric acid as an endogenous inhibitor of CD38. Elife. 13:RP96962, 2024.

Zhu S, Yoshida N, Matsushita R, Rahman MS, Kimura K: Circulation of COVID-19-related medicines on Japanese websites during the COVID-19 pandemic and their quality and authenticity. Am J Trop Med Hyg.111(5):1097-1106, 2024.

Arakawa H, Higuchi D, Takahashi E, Matsushita K, Nedachi S, Peng H, Kadoguchi M, Morimura K, Araki A, Kondo M, Ishiguro N, Jimbo Y, Tamai I. Three-dimensional Culture of Human Proximal Tubular Epithelial Cells for an in vitro Evaluation of Drug-induced Kidney Injury. J Pharm Sci. in press.

Schreiber R, Hori M, Takahashi C, Rahman MS, Nakao A, Zhu S, Zhu F, Yoshida N, Maekawa K, Kimura K. Falsified and problematic methandienone products available online: active pharmaceutical ingredient identification by portable Raman spectrometers and quantification by ultra-high-performance liquid chromatography–Fourier transform mass spectrometry. AAPS Open. 10: 5, 2024.

Hashiba S, Nakano M, Yokoseki I, Takahashi E, Kondo M, Jimbo Y, Ishiguro N, Arakawa H, Fukami T, Nakajima M. Cytochrome P450 and UDP-glucuronosyltransferase expressions, activities, and induction abilities in 3D-cultured human renal proximal tubule epithelial cells. Drug Metab Dispos. 2024.

Arakawa H, Ishida N, Nakatsuji T, Matsumoto N, Imamura R, Shengyu D, Araya K, Horike S, Tanaka-Yachi R, Kasahara M, Yoshioka T, Sumida Y, Ohmiya H, DaikokuT, Wakayama T, Nakamura K, Fujita K, Kato Y. Endoplasmic reticulum transporter OAT2 regulates drug metabolism and interaction. Biochem Pharmacol. 225, 2024.

Miyajima Y, Karashima S, Mizoguchi R, Kawakami M, Ogura K, Ogai K, Koshida A, Ikagawa Y, Ami Y, Zhu Q, Tsujiguchi H, Hara A, Kurihara S, Arakawa H, Nakamura H, Tamai I, Nambo H, Okamoto S. Prediction and causal inference of hyperuricemia using gut microbiota. Sci Rep. 14, 2024.

Fujita K, Isozumi N, Zhu Q, Matsubayashi M, Taniguchi T, Arakawa H, Shirasaka Y, Mori E, Tamai I. Unique Binding Sites of Uricosuric Agent Dotinurad for Selective Inhibition of Renal Uric Acid Reabsorptive Transporter URAT1. J Pharmacol Exp Ther. 390, 2024.

Imamura R, Sugimoto M, Horike SI, Terakawa J, Fujita K, Tamai I, Daikoku T, Kato Y, Arakawa H. Role of organic anion transporter NPT4 in renal handling of uremic toxin 3-indoxyl sulfate. J Pharm Sci. 113, 2024.

Fujita H, Arai S, Arakawa H, Hamamoto K, Kato H, Arai T, Nitta N, Hotta K, Hosokawa N, Ohbayashi T, Takahashi C, Inokuma Y, Tamai I, Yano S, Kunishima M, Watanabe Y. Drug­drug conjugates of MEK and Akt inhibitors for RAS-mutant cancers. Bioorg Med Chem. 102, 2024.

Wen S, Arakawa H, Yokoyama S, Shirasaka Y, Higashida H, Tamai I. Functional identification of soluble uric acid as an endogenous inhibitor of CD38. eLife, in press.

Scheidecker B, Poulain S, Sugimoto M, Kido T, Kawanishi T, Miyajima A, Kim S, Arakawa H, Kato Y, Nishikawa M, Danoy M, Sakai Y, Leclerc E. Dynamic, IPSC-derived Hepatic Tissue Tri-Culture System for the Evaluation of Liver Physiology in vitro. Biofarication. 16, 2024.

Ishida N, Katsura A, Takagaki K, Arakawa H, Shimada T, Mizuno S, Sai Y, Kato Y, Nakamura H, Suga Y, Matsushita R. Transdermal pilocarpine on the skin over salivary glands to increase salivation: an in vivo study. BMC Oral Health. 2;24(1), 2024.

Habuchi F, Yamaoka E, Ishida N, Shitanda K, Hashimoto M, Matsushita R. The relationship between psychological burden and providing assistance with taking medication among caregivers of patients with dementia: a cross-sectional study. Int J Pharm Pract. riae029, 2024.

Kurniawan A, Leo S, Inamatsu M, Funaoka S, Aihara T, Aiko M, Rei I, Sakura T, Arakawa H, Kato Y, Matsugi T, Esashika K, Shiraki N, Kume S, Shinha K, Kimura H, Nishikawa M, Sakai Y. Gut-Liver Microphysiological Systems Revealed Potential Crosstalk Mechanism Modulating Drug Metabolism. PNAS Nexus. 3(2), 2024.

Hashimoto K, Arakawa H, Imamura R, Nishimura T, Kitajima S, Sato T, Makiyama K, Ogawa T, Yokota S. A novel alternative method for long-term evaluation of　male reproductive toxicity and its recovery using a pre-pubertal mouse testis　organ culture system. J Appl Toxicol. 2024. 44(5), 2024.

Utami T, Danoy M, Khadim RR, Tokito F, Arakawa H, Kato Y, Kido T, Miyajima A, Nishikawa M, Sakai Y. A highly efficient cell culture method using oxygen-permeable PDMS-based honeycomb microwells produces functional liver organoids from human induced pluripotent stem cell-derived carboxypeptidase M liver progenitor cells. Biotechnol Bioeng. 121(4), 2024.

Scheidecker B, Poulain S, Sugimoto M, Arakawa H, Kim SH, Kawanishi T, Kato Y, Danoy M, Nishikawa M, Sakai Y. Mechanobiological stimulation in organ-on-a-chip systems reduces hepatic drug metabolic capacity in favor of regenerative specialization. Biotechnol Bioeng. 2024. 121(4), 2024.

Katsura H, Suga Y, Kubo A, Sugimura H, Kumatani K, Haruki K, Yonezawa M, Narita A, Ishijima R, Ikesuke H, Toi H, Takata N, Risk evaluation of proton pump inhibitors for panitumumab-related hypomagnesemia in patients with metastatic colorectal cancer. Biol Pharm Bull. 47, 2024.

2023年

Habuchi F, Ishida N, Matsushita R, Ishizaki J, Suga Y. Analysis of Atypical Antipsychotics-Induced Adverse Events Related to Diabetes Mellitus in Patients with Dementia Using the Japanese Adverse Drug Event Report Database. Ann Pharmacother. 2023.

Ishida N, Oshima Y, Katsura A, Imamura R, Arakawa H, Shimada T, Mizuno S, Sai Y, Suga Y, Matsushita R. Application Site of Transdermal Scopolamine Influences Efficacy and Drug Concentration in Salivary Glands in Rats. Biol Pharm Bull. 46(12), 2023.

Fujita K, Zhu Q, Arakawa H, Shirasaka Y, Tamai I. Potentiation of the Uricosuric Effect of Dotinurad by Trans-Inhibition of the Uric Acid Reabsorptive Transporter 1. Drug Metab Dispos. 51(11), 2023.

Arakawa H, Kawanishi T, Shengyu D, Nishiuchi T, Meguro-Horike M, Horike SI, Sugimoto M, Kato Y. Renal Pharmacokinetic Adaptation to Cholestasis Causes Increased Nephrotoxic Drug Accumulation by Mrp6 Downregulation in Mice. J Pharm Sci. 112(12), 2023.

Arakawa H, Nakazono Y, Matsuoka N, Hayashi M, Shirasaka Y, Hirao A, Tamai I. Induction of open-form bile canaliculus formation by hepatocytes for evaluation of biliary drug excretion. Commun Biol. 6(1), 2023.

Ishida N, Ono S, Suzuki R, Nojiri K, Ootsuki S, Zakoji N. Comparison of factors associated with drooling between intractable neuromuscular disease and cerebral palsy. J Clin Neurosci. 115, 2023.

Suzuki S, Sugawara H, Uchida M, Suga Y, Nakagawa T, Takase H, Multicenter prospective observational study on hospital pharmacist interventions to reduce potential inappropriate medications. Front Pharmacol. 14, 2023.

Sugawara H, Uchida M, Suzuki S, Suga Y, Uesawa Y, Nakagawa T, Takase H, Analyses of Respiratory Depression Associated with Opioids in Non-cancer Patients and Comparison with Cancer Patients in Japan using the Japanese Adverse Drug Event Report Database. J Nippon Med Sch. 90, 2023.

Tanaka R, Satoh Y, Suga Y, Nakagawa J, Miyazaki M, Hagiwara R, Uchida M, Takase H, Japanese Nationwide Comparative Survey of Medication Guidance provided by Certified and Non-certified Palliative Care Pharmacists. J Nippon Med Sch. 90, 2023.

Ishiguro N, Takahashi E, Arakawa H, Saito A, Kitagawa F, Kondo M, Morinaga G, Takatani M, Takahashi R, Kudo T, Mae SI, Kadoguchi M, Higuchi D, Nakazono Y, Tamai I, Osafune K, Jimbo Y. Improvement of Protein Expression Profile in Three-Dimensional Renal Proximal Tubular Epithelial Cell Spheroids Selected Based on OAT1 Gene Expression: A Potential In Vitro Tool for Evaluating Human Renal Proximal Tubular Toxicity and Drug Disposition. Drug Metab Dispos. 51(9), 2023.

Arakawa H, Kato Y. Emerging Roles of Uremic Toxins and Inflammatory Cytokines in the Alteration of Hepatic Drug Disposition in Patients with Kidney Dysfunction. Drug Metab Dispos. 51(9), 2023.

Tao F, Hanada S, Matsushima K, Arakawa H, Ishida N, Kato Y, Okimura S, Watanabe T, Kojima N. Enhancement and maintenance of hepatic metabolic functions by controlling 3D aggregation of cryopreserved human iPS cell-derived hepatocyte-like cells. J Biosci Bioeng. 135(2), 2023.

2022年

Nishikawa M, Ito H, Tokito F, Hirono K, Inamura K, Scheidecker B, Danoy M, Kawanishi T, Arakawa H, Kato Y, Esashika K, Miyasako H, Sakai Y. Accurate Evaluation of Hepatocyte Metabolisms on a Noble Oxygen-Permeable Material With Low Sorption Characteristics. Front Toxicol. 6;4, 2022.

Danoy M, Poulain S, Scheidecker B, Jellali R, Tauran Y, Leduc M, Bruce J, Gilard F, Gakiere B, Arakawa H, Kato Y, Kim SH. Influence of CPM-dependent sorting on the multi-omics profile of hepatocyte-like cells matured in microscale biochips. Biochem Eng J. 181, 2022.

Kadoguchi M, Arakawa H, Honda R, Hotta K, Shirasaka Y, Deguchi Y, Tamai I. Characterization of Aripiprazole Uptake Transporter in the Blood-Brain Barrier Model hCMEC/D3 Cells by Targeted siRNA Screening. Pharm Res. 39(7), 2022.

Arakawa H, Nagao Y, Nedachi S, Shirasaka Y, Tamai I. Evaluation of Platinum Anticancer Drug-Induced Kidney Injury in Primary Culture of Rat Kidney Tissue Slices by Using Gas-Permeable Plates. Biol Pharm Bull. 45(3). 2022.

Tsuboi H, Matsunaga M, Tsujiguchi H, Kannon T, Hosomichi K, Sato T, Atajima A, Yoshida N, Hara A, Nakamura H. Elevated ratio of serum anandamide to arachidonic acid intake in community-dwelling women with high depressive symptoms. Neuro Endocrinol Lett. 43(3), 2022.

Rahman MS, Yoshida N, Hanafusa M, Matsuo A, Zhu S, Stub Y, Takahashi C, Tsuboi H, Matsushita R, Maekawa K, Kimura K. Screening and quantification of undeclared PGF2α analogs in eyelash-enhancing cosmetic serums using LC-MS/MS. J Pharm Biomed Anal. 291, 2022.

Rahman MS, Yoshida N, Tsuboi H, Karmoker JR, Kabir N, Schaefermann S, Akimoto Y, Bhuiyan MA, Reza MS, Kimura K. A comprehensive analysis of selected medicines collected from private drug outlets of Dhaka city, Bangladesh in a simple random survey. Sci Rep. 12(1), 2022.

Futagi Y, Suga Y, Shimada T, Sai Y. Impact of antithymocyte globulin on blood cyclosporin A levels in aplastic anemia patients. Ann Hematol. 2022.

Yamada S, Suga Y, Morishita E, Asakura H. Effect of Anticoagulant/Antifibrinolytic Combination Therapy on Enhanced Fibrinolytic-Type Disseminated Intravascular Coagulation in End-of-Life Stage Solid Tumor Patients. J Palliat Med. 2022.

Uchida M, Suzuki S, Sugawara H, Suga Y, Kokubun H, Uesawa Y, Nakagawa T, Takase H. Multicentre prospective observational study on community pharmacist interventions to reduce inappropriate medications. Int J Pharma Pract. 30, 2022

Suga Y, Akita F, Yamada S, Morishita E, Asakura H. Recombinant human erythropoietin attenuates hepatic dysfunction by suppressing the hepatocellular Apoptosis in lipopolysaccharide-induced disseminated intravascular coagulation in rats. Biomed Rep. 16, 2022.

Noguchi-Shinohara M, Yuki-Nozaki S, Abe C, Mori A, Horimoto M, Yokogawa M, Ishida N, Suga Y, Ishizaki J, Ishimiya M, Nakamura H, Komai K, Nakamura H, Shibata M, Ohara T, Hata J, Ninomiya T, Yamada M. Diabetes Mellitus, Elevated Hemoglobin A1c, and Glycated Albumin Are Associated with the Presence of All-Cause Dementia and Alzheimer’s Disease: The JPSC-AD Study. Journal of Alzheimer’s Disease. 85(1), 2022.

Kashiwa M, Matsushita R. Difference in Cost-Effectiveness between First-Line and Third-Line or Later Nivolumab Therapy in Patients with HER2-Negative, Unresectable, Advanced or Recurrent Gastric or Gastro-Esophageal Junction Cancer in Japan. Biol Pharm Bull. 45(7), 2022.

2021年

Wen S, Arakawa H, Tamai I. CD38 activation by monosodium urate crystals contributes to inflammatory responses in human and murine macrophages. Biochem Biophys Res Commun. 3, 2021.

Shinha K, Nihei W, Nakamura H, Goto T, Kawanishi T, Ishida N, Yamazaki N, Imakura Y, Mima S, Inamura K, Arakawa H, Nishikawa M, Kato Y, Sakai Y, Kimura H. A Kinetic Pump Integrated Microfluidic Plate (KIM-Plate) with High Usability for Cell Culture-Based Multiorgan Microphysiological Systems. Micromachines (Basel). 24;12(9), 2021.

Danoy M, Tauran Y, Poulain S, Jellali R, Bruce J, Leduc M, Le Gall M, Koui Y, Arakawa H, Gilard F, Gakiere B, Kato Y, Plessy C, Kido T, Miyajima A, Sakai Y, Leclerc E. Investigation of the hepatic development in the coculture of hiPSCs-derived LSECs and HLCs in a fluidic microenvironment. APL Bioeng. 10;5(2), 2021.

Nakazono Y, Arakawa H, Nishino M, Yamaki I, Oba T, Tomotoshi K, Kakinuma C, Ogihara T, Tamai I. Drug Transcellular Transport Assay Using a High Porosity Honeycomb Film. Biol Pharm Bull. 44(5), 2021.

Shinohara M, Arakawa H, Oda Y, Shiraki N, Sugiura S, Nishiuchi T, Satoh T, Iino K, Leo S, Kato Y, Araya K, Kawanishi T, Nakatsuji T, Mitsuta M, Inamura K, Goto T, Shinha K, Nihei W, Komori K, Nishikawa M, Kume S, Kato Y, Kanamori T, Sakai Y, Kimura H. Coculture with hiPS-derived intestinal cells enhanced human hepatocyte functions in a pneumatic-pressure-driven two-organ microphysiological system. Sci Rep. 8;11(1), 2021.

Danoy M, Tauran Y, Poulain S, Jellali R, Bruce J, Leduc M, Le Gall M, Gilard F, Kido T, Arakawa H, Araya K, Mori D, Kato Y, Kusuhara H, Plessy C, Miyajima A, Sakai Y, Leclerc E. Multi-omics analysis of hiPSCs-derived HLCs matured on-chip revealed patterns typical of liver regeneration. Biotechnol Bioeng. 118(10), 2021.

Hashizume H, Fukami T, Mishima K, Arakawa H, Mishiro K, Zhang Y, Nakano M, Nakajima M. Identification of an isoform catalyzing the CoA conjugation of nonsteroidal anti-inflammatory drugs and the evaluation of the expression levels of acyl-CoA synthetases in the human liver. Biochem Pharmacol. 183, 2021.

Tsuboi H, Takakura Y, Tsujiguchi H, Miyagi S, Suzuki K, Nguyen TTT, Pham KO, Shimizu Y, Kambayashi Y, Yoshida N, Hara A, Nakamura H. Validation of the Japanese version of the center for epidemiologic studies depression scale—Revised: A preliminary analysis. Behav Sci. 11(8), 2021.

Zhu S, Yoshida N, Tsuboi H, Matsushita R, Kimura K. Quality and authenticity of metformin tablets circulating on Japanese websites. Ther Innov Regul Sci. 55(4) 6, 2021.

Rahman MS, Yoshida Y, Tsuboi H, Ishii Y, Akimoto Y, Kimura K. Small-scale dissolution test screening tool to select potentially substandard and falsified (SF) medicines requiring full pharmacopoeial analysis. Sci Rep. 11(1), 2021.

Sanada T, Yoshida N, Kimura K, Tsuboi H. Detection method of falsified medicines by using a low-cost Raman scattering spectrometer combined with soft independent modeling of class analogy and partial least squares discriminant analysis. Biol Pharm Bull. 44(5), 2021.

Sanada T, Ohnishi M, Yoshida N, Kimura K, HTsuboi H. Quality assessment of Diflucan® tablets distributed online. Medicine Access @ Point of Care.25 , 2021.

Rahman MS, Yoshida N, Tsuboi H, Maeda E, Ibarra AVV, Zin T, Akimoto Y, Tanimoto T, Kimura K. Patient safety and public health concerns: poor dissolution rate of pioglitazone tablets obtained from China, Myanmar and internet sites. BMC Pharmacol Toxicol. 22(1), 2021.

Sakuda M, Yoshida N, Koide T, Keila T, Kimura K, Hirohito Tsuboi. Clarification of the internal structure and factors of poor dissolution of substandard roxithromycin tablets by near-infrared chemical imaging. Int J Pharm. 596, 2021.

Suga Y, Tashiro K, Staub Y, Komura S, Yamada S, Morishita E, Asakura H. Potentiality of tPA continuous infusion on multiple organ failure of lipopolysaccharide-induced disseminated intravascular coagulation in rats. Thromb Res. 206, 2021.

Suga Y, Takahashi Y, Shimada T, Yamada S, Morishita E, Asakura H. Effect of NOS inhibitors and anticoagulants on nitric oxide production in a tissue-factor induced rat DIC model: In Vivo. 35, 2021.

Suga Y, Kubo A, Katsura H, Staub Y, Tashiro K, Yamada S, Morishita M, Asakura H. Detailed exploration of pathophysiology involving inflammatory status and bleeding symptoms between lipopolysaccharide- and tissue factor-induced disseminated intravascular coagulation in rats. Int J Hematol. 114, 2021.

Isoda K, Nakade J, Suga Y, Fujita A, Shimada T, Sai Y. Initial serum C-reactive protein level as a predictor of increasing serum vancomycin concentration during treatment. Ther Drug Monit. 43, 2021.

Nishiyama A, Staub Y, Suga Y, Fujita M, Tanimoto A, Ohtsubo K, Yano S, Sarcopenia may influence the prognosis in advanced thyroid cancer patients treated with molecular targeted therapy. In Vivo. 35, 2021.

Hayashi K, Noguchi-Shinohara M, Sato T, Hosomichi K, Kannon T, Abe C, Domoto C, Yuki-Nozaki S, Mori A, Horimoto M, Yokogawa M, Sakai K, Iwasa K, Komai K, Ishimiya M, Nakamura H, Ishida N, Suga Y, Ishizaki J, Ishigami A, Tajima A, Yamada M. Effects of functional variants of vitamin C transporter genes on apolipoprotein E E4-associated risk of cognitive decline: The Nakajima study. PLOS ONE. 16(11), 2021.

Ishida N, Tokumoto Y, Suga Y, Noguchi-Shinohara M, Abe C, Yuki-Nozaki S, Mori A, Horimoto M, Hayashi K, Iwasa K, Yokogawa M, Ishimiya M, Nakamura H, Komai K, Matsushita R, Ishizaki J, Yamada M. Factors Associated with Self-reported Medication Adherence in Japanese Community-dwelling Elderly Individuals: The Nakajima Study. YAKUGAKU ZASSHI. 141(5), 2021.

Kashiwa M, Matsushita R. Cost-effectiveness of preemptive skin treatment to prevent skin-toxicity caused by panitumumab in third-line therapy for KRAS wild type metastatic colorectal cancer in Japan. J Pharm Health Care Sci. 7(1), 2021.

●和文

2024年

小林星太, 伊藤朱里, 川上紗枝, 中出恵里奈, 矢野涼子, 長岡宏一, 庄源民湖, 橋本昌子, 石田奈津子. パーキンソン病患者への服薬指導に関する保険薬剤師の現状調査－石川県金沢市におけるアンケート調査より－. 日本薬剤師会雑誌. 76, 2024.

2023年

荒川大. 尿酸の炎症反応を介した慢性腎臓病進展メカニズムと腎臓病態評価モデルの構築. 月刊細胞. 55, 2023.

Arakawa H. Evaluation and Clarification of Enterohepatic Interactions in Pharmacokinetics: YAKUGAKU ZASSHI. 143(2), 2023.

2022年

小林星太, 大木孝弘, 金谷祐希, 寺沢明宏, 徳久宏子, 菅幸生. 終末期がん患者に対する保険薬剤師の緊急在宅訪問に関する実態調査. 医療薬学. 48, 2022.

2021年

菅幸生, スタッブ由紀子, 田代精亨, 山田真也, 森下英理子, 朝倉英策. LPS誘発DICモデルに対するtPA投与による臓器障害の改善. 日本検査血液学会誌. 22, 2021.

●総説

2025年

Arakawa H, Matsushita K, Ishiguro N. Advanced in vitro evaluation of drug-induced kidney injury using microphysiological systems in drug discovery and development. Drug Metab Pharmacokinet. in press

2024年

吉田直子. 偽造医薬品の脅威. Precision Medicine 7(12): 53-58 (1001-1006), 2024.

Yoshida N. Research on the development of methods for detection of substandard and falsified medicines by clarifying their pharmaceutical characteristics using modern technology. Biol Pharm Bull. 47(5), 2024.

2022年

吉田直子. 分光分析およびX線CTによる偽造医薬品の識別. 光学. 51(9), 2022.

作田未来, 吉田直子. 低中所得国で製造・流通する低品質医薬品の原因究明に関する研究〜ケミカルイメージングによる錠剤内の成分分散状況の可視化〜. 製剤機械技術学会誌. 31(2), 2022.

●著書

2022年

吉田直子. 薬学と社会　薬事関連法・制度, 改訂第2版（部分執筆：販売等および製造・販売等の禁止, 偽造医薬品, 医薬品の輸入）. 南江堂, 2022.

石田奈津子. 検査値と画像データから読み解く 薬効・副作用評価マニュアル（部分執筆：第7章23 パーキンソン病治療薬）.　医学書院. 2022.

2021年

吉田直子. 薬学と社会　薬事関連法・制度, 更新情報リーフレット（部分執筆：販売等および製造・販売等の禁止, 偽造医薬品, 医薬品の輸入）. 南江堂, 2021.

菅幸生. マナビジュアルノート がん薬物療法副作用対策＆曝露対策（部分執筆：血液毒性、血管外漏出、免疫チェックポイント阻害薬）. 南山堂. 2021.